Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
28 02 2023
Historique:
pubmed: 10 1 2023
medline: 3 3 2023
entrez: 9 1 2023
Statut: ppublish

Résumé

Every year, dengue virus (DENV) causes one hundred million infections worldwide that can result in dengue disease and severe dengue. Two other mosquito-borne flaviviruses, i.e., Zika virus (ZIKV) and West Nile virus (WNV), are responsible of prolonged outbreaks and are associated with severe neurological diseases, congenital defects, and eventually death. These three viruses, despite their importance for global public health, still lack specific drug treatments. Here, we describe the structure-guided discovery of small molecules with pan-flavivirus antiviral potential by a virtual screening of ~1 million structures targeting the NS3-NS5 interaction surface of different flaviviruses. Two molecules inhibited the interaction between DENV NS3 and NS5

Identifiants

pubmed: 36622141
doi: 10.1128/mbio.03097-22
pmc: PMC9973282
doi:

Substances chimiques

Antiviral Agents 0
Viral Nonstructural Proteins 0
NS3 protein, flavivirus 0
NS5 protein, flavivirus 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0309722

Références

J Biol Chem. 2015 Jan 23;290(4):2379-94
pubmed: 25488659
Lancet Infect Dis. 2020 Dec;20(12):1446-1456
pubmed: 32673593
Cell Res. 2017 Aug;27(8):1046-1064
pubmed: 28685770
Antiviral Res. 2013 Sep;99(3):318-27
pubmed: 23748148
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):
pubmed: 33441483
Viruses. 2021 May 21;13(6):
pubmed: 34064113
Asian Pac J Trop Med. 2017 Mar;10(3):220-228
pubmed: 28442105
Sci Rep. 2017 Jan 31;7:41697
pubmed: 28139770
Nucleic Acids Res. 2009 Jan;37(Database issue):D284-90
pubmed: 18931373
Viruses. 2017 Apr 24;9(4):
pubmed: 28441781
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
ACS Infect Dis. 2020 Oct 9;6(10):2616-2628
pubmed: 32866370
Rev Med Virol. 2020 Jul;30(4):e2101
pubmed: 32101634
Antiviral Res. 2017 Jul;143:218-229
pubmed: 28461069
J Chem Inf Model. 2009 Jan;49(1):84-96
pubmed: 19125657
Int J Mol Sci. 2019 Jul 20;20(14):
pubmed: 31330841
Biochem Biophys Res Commun. 2013 Oct 25;440(3):393-8
pubmed: 24070610
Elife. 2022 Mar 16;11:
pubmed: 35293862
Antiviral Res. 2018 Feb;150:217-225
pubmed: 29288700
Cancer Lett. 2020 Feb 1;470:115-125
pubmed: 31693922
Antiviral Res. 2019 May;165:55-64
pubmed: 30885750
J Virol. 2020 Oct 14;94(21):
pubmed: 32796069
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8994-8
pubmed: 8090758
Sci Rep. 2018 Mar 15;8(1):4653
pubmed: 29545578
PLoS Pathog. 2016 Aug 08;12(8):e1005737
pubmed: 27500641
J Biol Chem. 2007 Apr 6;282(14):10678-89
pubmed: 17287213
J Biol Chem. 2011 Apr 22;286(16):14362-72
pubmed: 21349834
Eur J Med Chem. 2019 Aug 15;176:431-455
pubmed: 31128447
J Biomol NMR. 2001 Dec;21(4):349-59
pubmed: 11824754
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31061163
mBio. 2017 Apr 25;8(2):
pubmed: 28442607
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6247-52
pubmed: 22474359
N Engl J Med. 2019 Oct 10;381(15):1444-1457
pubmed: 31597021
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32690644
J Virol. 2007 May;81(9):4753-65
pubmed: 17301146
Lancet. 2017 Nov 4;390(10107):2099-2109
pubmed: 28647173
Nat Rev Drug Discov. 2017 Aug;16(8):565-586
pubmed: 28473729
Antiviral Res. 2015 Oct;122:12-9
pubmed: 26241002
J Med Chem. 2015 Jun 25;58(12):4964-75
pubmed: 26039671
Nat Microbiol. 2020 Jun;5(6):796-812
pubmed: 32367055
Nat Rev Dis Primers. 2016 Aug 18;2:16055
pubmed: 27534439
Antimicrob Agents Chemother. 2014 Nov;58(11):6615-26
pubmed: 25155603
Emerg Microbes Infect. 2020 Dec;9(1):2404-2416
pubmed: 33078696
Sci Transl Med. 2021 Feb 3;13(579):
pubmed: 33536278
Cells. 2022 Feb 18;11(4):
pubmed: 35203378
Nature. 2021 Oct;598(7881):504-509
pubmed: 34616043
Int J Mol Sci. 2020 Nov 30;21(23):
pubmed: 33266206
Front Cell Infect Microbiol. 2017 Jul 12;7:317
pubmed: 28748176
ACS Med Chem Lett. 2020 Mar 19;11(5):773-782
pubmed: 32435384
Cell Rep. 2017 Dec 12;21(11):3032-3039
pubmed: 29241533
Antiviral Res. 2017 Sep;145:44-53
pubmed: 28733114
Int J Mol Sci. 2019 Oct 30;20(21):
pubmed: 31671583
Antiviral Res. 2019 Mar;163:156-178
pubmed: 30597183
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33375140
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0234920
pubmed: 34001508

Auteurs

Marta Celegato (M)

Department of Molecular Medicine, University of Padua, Padua, Italy.

Mattia Sturlese (M)

Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.

Vivian Vasconcelos Costa (V)

Departamento de Morfologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Marta Trevisan (M)

Department of Molecular Medicine, University of Padua, Padua, Italy.

Angélica Samer Lallo Dias (AS)

Departamento de Bioquímica e Imunologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Ingredy Beatriz Souza Passos (IB)

Departamento de Morfologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Celso Martins Queiroz-Junior (CM)

Departamento de Morfologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Lorenzo Messa (L)

Department of Molecular Medicine, University of Padua, Padua, Italy.

Annagiulia Favaro (A)

Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.

Stefano Moro (S)

Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.

Mauro Martins Teixeira (MM)

Departamento de Bioquímica e Imunologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Arianna Loregian (A)

Department of Molecular Medicine, University of Padua, Padua, Italy.

Beatrice Mercorelli (B)

Department of Molecular Medicine, University of Padua, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH